Literature DB >> 28527518

Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.

Mohamed El-Rabbany, Adam Sgro, David K Lam, Prakeshkumar S Shah, Amir Azarpazhooh.   

Abstract

BACKGROUND: The effectiveness of management strategies used for the treatment of medication-related osteonecrosis of the jaw (MRONJ) remains poorly understood. The authors evaluated systematically the effectiveness of the various treatment modalities used for MRONJ. TYPES OF STUDIES REVIEWED: The authors conducted a comprehensive search of MEDLINE, Embase, the Cochrane Library, and Scopus to identify randomized controlled trials, nonrandomized controlled trials, and prospective cohort studies to evaluate comparatively the effectiveness of management strategies for the treatment of MRONJ. The authors conducted the identification of eligible studies in duplicate and synthesized the extracted data by means of a meta-analysis, when feasible.
RESULTS: The authors found 13 studies with a medium-to-high risk of bias that met the inclusion criteria of this review. The authors found that, compared with medical treatment of local antimicrobials with or without systemic antimicrobials, the study investigators associated surgical treatment with higher odds of complete resolution of the condition (2 studies; 76 participants; unadjusted odds ratio, 3.55; 95% confidence interval, 1.12 to 11.19). The effectiveness of other therapies, such as bisphosphonate drug holidays, teriparatide, and hyperbaric oxygen, was uncertain. CONCLUSIONS AND PRACTICAL IMPLICATIONS: On the basis of the results of an unadjusted analysis, the results of the studies that were deemed to be medium to low quality and to have medium-to-low statistical power suggested that there are higher odds of resolving MRONJ with surgical treatment compared with medical treatment. High-quality research is required for conclusive statements to be made regarding treatment strategies for management of MRONJ.
Copyright © 2017 American Dental Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Osteonecrosis; bisphosphonate-associated osteonecrosis of the jaw; bone; medication-related osteonecrosis of the jaw; oral and maxillofacial surgery; osteonecrosis of the jaw

Mesh:

Substances:

Year:  2017        PMID: 28527518     DOI: 10.1016/j.adaj.2017.04.002

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN: 0002-8177            Impact factor:   3.634


  15 in total

Review 1.  Anabolic agents: what is beyond osteoporosis?

Authors:  Y Liu; A E Levack; E Marty; O Or; B P Samuels; M Redko; J M Lane
Journal:  Osteoporos Int       Date:  2018-04-07       Impact factor: 4.507

2.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

Review 3.  Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.

Authors:  Athanasios D Anastasilakis; Jessica Pepe; Nicola Napoli; Andrea Palermo; Christos Magopoulos; Aliya A Khan; M Carola Zillikens; Jean-Jacques Body
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

4.  A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer.

Authors:  Morten Schiodt; Saroj Vadhan-Raj; Mark S Chambers; Ourania Nicolatou-Galitis; Constantinus Politis; Ruxandra Coropciuc; Stefano Fedele; Danielle Jandial; Jeffrey Zhang; Haijun Ma; Deborah P Saunders
Journal:  Support Care Cancer       Date:  2017-12-23       Impact factor: 3.603

5.  Application of Autologous Platelet-Rich Plasma on Tooth Extraction Site Prevents Occurence of Medication-Related Osteonecrosis of the Jaws in Rats.

Authors:  Luan Felipe Toro; João Martins de Mello-Neto; Fernanda Furuse Ventura Dos Santos; Letícia Chaves Ferreira; Cristian Statkievicz; Luciano Tavares Ângelo Cintra; João Paulo Mardegan Issa; Rita Cássia Menegati Dornelles; Juliano Milanezi de Almeida; Maria José Hitomi Nagata; Valdir Gouveia Garcia; Leticia Helena Theodoro; Cláudio Aparecido Casatti; Edilson Ervolino
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

6.  Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study.

Authors:  Na Rae Choi; Jung Han Lee; Jin Young Park; Dae Seok Hwang
Journal:  Int J Environ Res Public Health       Date:  2020-11-26       Impact factor: 3.390

Review 7.  Interventions for managing medication-related osteonecrosis of the jaw.

Authors:  Natalie H Beth-Tasdogan; Benjamin Mayer; Heba Hussein; Oliver Zolk
Journal:  Cochrane Database Syst Rev       Date:  2017-10-06

8.  Use of Platelet Rich Fibrin (PRF)-Based Autologous Membranes for Tooth Extraction in Patients under Bisphosphonate Therapy: A Case Report.

Authors:  Alberto Pispero; Ivan Bancora; Antonious Khalil; Dario Scarnò; Elena M Varoni
Journal:  Biomedicines       Date:  2019-11-10

9.  The effect of pamidronate delivery in bisphosphonate-naïve patients on neutrophil chemotaxis and oxidative burst.

Authors:  Jeffrey W Chadwick; Howard C Tenenbaum; Chun-Xiang Sun; Robert E Wood; Michael Glogauer
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

Review 10.  Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw.

Authors:  Lina He; Xiangyu Sun; Zhijie Liu; Yanfen Qiu; Yumei Niu
Journal:  Int J Oral Sci       Date:  2020-10-21       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.